# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Nikola Tesla (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI009-SYN-TD
- Date: 1902-04-07
- Fictional facility: St. Posthumous Health Center
- Fictional author: Branimir Kovač-Holt, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Twelve-week OCD treatment review. **S**

## History of present illness

Mr. Tesla returns twelve weeks after starting sertraline and six weeks after the increase to 100 mg. At the nurse telephone check two weeks after the increase he reported two days of loose stools and no other side effects, and he has missed no doses. He has had eleven ERP sessions. He washes about 12 times a day, shook hands with an investor last week, and eats most meals without calculating. Counting steps and repeating actions in threes still take about an hour a day. His hands have healed. He sleeps about five and a half hours. He has had no suicidal thoughts. **S**

| Element | Detail |
|---|---|
| Interval change | Washing about 12 times a day; shook hands with an investor; most meals without calculating |
| Psychotherapy | Eleven ERP sessions |
| Rituals | About an hour a day of counting and repeating |
| Hands | Healed |
| Safety | No suicidal thoughts |
| Y-BOCS | 19, down from 28 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Gastrointestinal | Negative | Two days of loose stools after the increase; none now |
| Integumentary | Negative | Hands healed |
| Psychiatric | Positive | Counting and repeating still present; mood better; no suicidal thoughts |

3 systems reviewed. **S**

## Current medications

- Sertraline 50 mg oral tablet, three tablets (150 mg) by mouth each morning **S**
- White petrolatum ointment, apply to both hands after each wash and at bedtime **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/74 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 65.2 kg; BMI 18.4 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Slim; relaxed |
| Skin | Examined with his agreement: skin of both hands intact, without redness or fissures |
| Mental status | Engaged and wry; mood "much freer"; affect reactive; good insight; no suicidal ideation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Obsessive-compulsive disorder, partial response** (F42.2). Y-BOCS 19, down 32 percent from 28: a partial response, just short of the 35 percent that defines response, after six weeks at 100 mg. Tolerating sertraline well. Suicide risk remains low. **S**
   - Increase sertraline to 150 mg each morning; nurse telephone check in two weeks.
   - Continue weekly ERP, focused on counting and repeating; therapist to rate the Y-BOCS at about week eighteen.
   - Collaborative safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed.
2. **Irritant hand dermatitis, resolved** (L24.9). Healed with fewer washes and petrolatum. **S**
   - Petrolatum as needed.
3. **Underweight from food rituals** (R63.6). 65.2 kg, BMI 18.4. **S**
   - Continue three meals a day.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Y-BOCS severity score (recorded in the note; no LOINC code found) | At baseline and about every 4 to 6 weeks during acute treatment | Completed today | 19, down 32 percent from 28: partial response; dose increased to 150 mg |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9 when given) | Every visit during acute treatment | Completed today | No suicidal thoughts, intent, plan, or behavior since the last visit. Safety plan reviewed |
| Medication safety | Sertraline adherence and adverse effects (nausea, diarrhea, sleep, activation, sexual effects) | Every visit and two weeks after each dose increase | Completed today | Nurse call two weeks after the last increase: two days of loose stools; no missed doses; dose increased to 150 mg with a nurse call in two weeks |
| Self-management | Exposure and response prevention attendance and homework | Every visit during acute treatment | Completed today | Eleven sessions; handshake and most meals without calculating |
| Examination | Weight and BMI | Every visit while underweight | Completed today | 65.2 kg, BMI 18.4 |
| Examination | Hand skin | Every visit while dermatitis is present | Completed today | Healed |
| Self-management | Sleep diary | Every visit during acute treatment | Completed today | About five and a half hours a night |
| Medication safety | Antipsychotic augmentation monitoring (weight, glucose, lipids, movement) | Only if an antipsychotic is added | Not indicated | No augmentation; responding to sertraline and ERP |

## Goal progress

- Y-BOCS down by at least 35 percent (treatment response) by twenty-four weeks. In progress; target 1902-06-30. **S**
- Rituals under one hour a day, with meals eaten without calculating. In progress; target 1902-06-30. **S**
- BMI at least 18.5 with three meals a day. In progress; target 1902-06-30. **S**
- Hands healed, with washing under 15 times a day. Outcome by 1902-04-07: Skin healed; washing about 12 times a day by twelve weeks. **S**
- At least six hours of sleep most nights. In progress; target 1902-06-30. **S**

## Medication changes

- Stopped: Sertraline 100 mg oral tablet, one tablet by mouth each morning **S**
- Started: Sertraline 50 mg oral tablet, three tablets (150 mg) by mouth each morning **S**

## Guideline basis

- Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007), American Psychiatric Association
- Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013), American Psychiatric Association
- Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005), National Institute for Health and Care Excellence
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- Nurse telephone check in two weeks; review in twelve weeks, after at least eight weeks at 150 mg. **S**
- Next scheduled visit 1902-06-30: twenty-four-week OCD treatment review. **S**
